NCT01497626 2016-02-17Lapatinib and Bortezomib in Patients With Advanced MalignanciesGeorgetown UniversityPhase 1 Terminated15 enrolled
NCT00682279 2015-04-17A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid TumorsGlaxoSmithKlinePhase 1 Withdrawn